Natural Health Trends Valuation
Is NAH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NAH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NAH (€5) is trading above our estimate of fair value (€3.15)
Significantly Below Fair Value: NAH is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NAH?
Key metric: As NAH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is NAH's PE Ratio? | |
|---|---|
| PE Ratio | 83.4x |
| Earnings | US$754.00k |
| Market Cap | US$62.90m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | -19.8x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does NAH's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 39.7x | ||
A260930 CTK | 84.8x | 92.3% | ₩118.7b |
4932 Almado | 22.9x | n/a | JP¥9.9b |
SNYR Synergy CHC | 10.4x | n/a | US$53.1m |
SUNZEN Sunzen Biotech Berhad | 40.8x | n/a | RM 245.8m |
NAH Natural Health Trends | 83.4x | n/a | €62.9m |
Price-To-Earnings vs Peers: NAH is expensive based on its Price-To-Earnings Ratio (83.4x) compared to the peer average (40.1x).
Price to Earnings Ratio vs Industry
How does NAH's PE Ratio compare vs other companies in the European Personal Products Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: NAH is expensive based on its Price-To-Earnings Ratio (83.4x) compared to the European Personal Products industry average (22.4x).
Price to Earnings Ratio vs Fair Ratio
What is NAH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 83.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NAH's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Cheerwin Group
HK$2.5b
An investment holding company, manufactures and trades household insecticides and repellents, household cleaning, air care, personal care, pets and pet products, and other products in the People’s Republic of China.
1RQ
HK$0.22
7D
0.9%
1Y
33.3%
Reynolds Consumer Products
US$5.8b
Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
3ZT
US$25.80
7D
0.8%
1Y
8.4%
L'Oréal
€175.9b
Through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.
LOR
€331.10
7D
0.4%
1Y
-24.2%